InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
6
T+90 hit rate
33%
T+90 mean return
-0.2%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by De Witte Jan, Director. Officer active across 2 companies, notably RESMED INC. Aggregated, 22 reports have been recorded. Breakdown: 1 buy · 6 sells. Total volume traded: €1.6m. History available since 11 November 2021. The latest transaction was filed on 25 November 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to De Witte Jan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
2,055 shares@ US$255.0033.8% of flowReMed Common StockSEC:0000943819-25-000181:0
1,073 shares0ReMed Common StockSEC:0000943819-25-000166:0
487 shares@ US$250.2511.8% of flowReMed Common StockSEC:0000943819-25-000115:0
2,000 shares@ US$243.4753.4% of flowReMed Common StockSEC:0001127602-25-015264:0
1,083 shares0ReMed Common StockSEC:0001127602-24-027902:0
796 shares@ US$248.8123.0% of flowReMed Common StockSEC:0001127602-24-027277:0
9,814 shares0Common StockSEC:0000917520-24-000109:0
360 shares@ US$218.298.9% of flowReMed Common StockSEC:0001127602-24-016231:0
360 shares@ US$218.298.9% of flowReMed Common StockSEC:0001127602-24-015777:0
205 shares0Common StockSEC:0000917520-24-000037:0
346 shares0Common StockSEC:0000917520-24-000025:0
597 shares0Common StockSEC:0000917520-24-000002:0
1,768 shares0ReMed Common StockSEC:0001127602-23-028090:0
9,814 shares0Common StockSEC:0001209191-23-054323:0
205 shares0Common StockSEC:0001209191-23-052775:0
7,792 shares@ US$38.499259.2% of flowCommon StockSEC:0001209191-23-033676:0
Canonical exit: 30 Aug 2023 (T+90)
3,842 shares@ US$52.8740.8% of flowCommon StockSEC:0001209191-23-018446:0
8,848 shares0Common StockSEC:0001209191-23-009758:0
431 shares0Common StockSEC:0001209191-23-004012:0
1,122 shares0ReMed Common StockSEC:0001127602-22-026159:0
956 shares0ResMed Common StockSEC:0000943819-21-000034:0
104 shares@ US$259.470.0001% mcap50.0% of flowReMed Common StockSEC:0001127602-21-029093:0
22 of 22 declarations
About De Witte Jan
Jan De Witte is a Director at ResMed Inc. As a board member, he participates in the governance of the company and the development of its strategy. ResMed Inc. is a company specializing in health technologies, particularly solutions for respiratory disorders. De Witte leverages his expertise to help steer the company toward new growth opportunities and improve the quality of healthcare.
